DRUG DELIVERY
Scope & Guideline
Catalyzing Progress in Drug Delivery Methodologies
Introduction
Aims and Scopes
- Nanoparticle-based Drug Delivery Systems:
This area emphasizes the development and characterization of nanoparticles, including liposomes, solid lipid nanoparticles, and nanocrystals, for the targeted delivery of therapeutic agents. - Transdermal and Topical Formulations:
Research on various techniques to enhance the transdermal delivery of drugs, including microneedles, gels, and emulsions, focusing on improving bioavailability and therapeutic efficacy. - Biopolymer and Natural Compound Delivery:
Utilization of biopolymers and natural compounds in drug delivery systems, highlighting their potential in improving drug solubility and stability. - Smart and Responsive Drug Delivery Systems:
Investigation into stimuli-responsive systems, such as pH-sensitive and thermosensitive formulations, aimed at achieving controlled and targeted drug release. - Nanomedicine in Cancer Treatment:
Exploration of nanomedicine approaches for cancer therapy, including the use of targeted delivery systems to enhance the efficacy and reduce side effects of chemotherapeutics. - Computational and AI-Assisted Drug Design:
Application of computational methods and artificial intelligence in drug delivery research to optimize formulations and predict pharmacokinetic properties.
Trending and Emerging
- Nanotechnology in Drug Delivery:
The application of nanotechnology continues to expand, with a growing focus on engineered nanoparticles and nanocarriers for improved drug delivery, particularly in oncology and chronic diseases. - Multi-Drug Delivery Systems:
There is an increasing trend towards the development of multi-drug delivery systems that allow for co-delivery of therapeutic agents, addressing issues such as drug resistance in cancer therapy. - Personalized Medicine Approaches:
Research is increasingly oriented towards personalized medicine strategies, where drug delivery systems are tailored to individual patient profiles, enhancing treatment efficacy and minimizing side effects. - AI and Machine Learning Applications:
Integration of artificial intelligence and machine learning in drug formulation and delivery systems is gaining traction, aimed at optimizing design and predicting drug behavior. - Sustainable and Green Drug Delivery Technologies:
Emerging interest in sustainable practices within drug delivery systems, including the use of biodegradable materials and eco-friendly manufacturing processes. - Regenerative Medicine and Advanced Therapies:
The application of drug delivery systems in regenerative medicine, including stem cell therapies and tissue engineering, is a rapidly developing area that is gaining attention.
Declining or Waning
- Conventional Drug Delivery Methods:
Traditional drug delivery methods, such as oral and intravenous routes without advanced formulations, are seeing a decrease in focus as newer, more innovative methods gain traction. - Herbal and Traditional Medicine Applications:
Although still relevant, the specific application of traditional herbal medicines in drug delivery has decreased, possibly due to a shift towards more clinically validated pharmaceutical approaches. - Single-Drug Delivery Systems:
Research that focuses solely on the delivery of single drugs without combination therapies or multifunctional systems appears to be declining, reflecting an evolving emphasis on combination therapies. - In Vivo Studies with Limited Scope:
Studies focusing exclusively on limited in vivo models without broader applicability or translational potential are becoming less common as the field moves towards more comprehensive, multi-faceted research. - Basic Formulation Research:
The emphasis on purely theoretical or basic formulation studies without practical application or translational research has diminished, as the journal increasingly favors studies with clear clinical implications.
Similar Journals
Future Journal of Pharmaceutical Sciences
Innovating Today for a Healthier TomorrowThe Future Journal of Pharmaceutical Sciences, published by Springer, stands as a vital resource in the realm of pharmaceutical research and innovation. Recognized for its open access initiative since 2015, this journal promotes extensive dissemination of cutting-edge discoveries, fostering collaboration among researchers, industry professionals, and students alike. With an ISSN of 2314-7245 and an E-ISSN of 2314-7253, it aims to bridge the gap between laboratory research and practical applications in the pharmaceutical sciences. Although specific metrics like HIndex and Scopus ranks are currently unavailable, the journal's commitment to high-quality, peer-reviewed content positions it as a promising platform for advancing pharmaceutical science. By engaging with this journal, contributors and readers can participate in the vibrant discourse shaping the future of drug development, therapeutic strategies, and healthcare solutions.
Advanced Pharmaceutical Bulletin
Catalyzing Collaboration in Cutting-edge Pharmaceutical ResearchAdvanced Pharmaceutical Bulletin, an esteemed journal published by Tabriz University of Medical Sciences & Health Services, serves as a pivotal platform for disseminating groundbreaking research in the field of pharmaceutical sciences. Since its inception in 2011, this open-access journal has dedicated itself to advancing knowledge in pharmacology, toxicology, and pharmaceutics, boasting an impressive Q1 ranking in miscellaneous categories and Q2 in pharmaceutical science as of 2023. The journal is noted for its rigorous peer-review process, ensuring that published work meets the highest standards of scientific inquiry. With notable rankings, including 7th out of 80 in general pharmacology and toxicology, it sits in the 91st percentile, highlighting its significance in the research community. Researchers and practitioners alike can access cutting-edge findings and innovative methodologies, promoting collaboration and knowledge within the scientific community. Based in Tabriz, Iran, the journal remains committed to fostering research excellence, making it an invaluable resource for scholars and professionals eager to contribute to the dynamic field of pharmaceuticals.
Current Drug Delivery
Transforming drug delivery with cutting-edge research.Current Drug Delivery, published by Bentham Science Publishers Ltd, serves as a vital platform for advancing the field of pharmaceutical sciences. With an ISSN of 1567-2018 and an E-ISSN of 1875-5704, this esteemed journal focuses on all aspects of drug delivery systems, encompassing innovative research and developments that aim to improve therapeutics and patient outcomes. Operating from the United Arab Emirates, it has an impressive standing reflected in its 2023 Q2 ranking in Pharmaceutical Sciences and a notable position within the 62nd percentile in Scopus’s Pharmacology, Toxicology, and Pharmaceutics category. The journal not only acts as an essential resource for researchers and professionals but it also encourages the dissemination of knowledge among students and budding scientists. With the latest articles and reviews converging from 2004 to 2024, Current Drug Delivery remains committed to offering high-quality content that enhances understanding and sparks innovation in drug delivery mechanisms.
Therapeutic Delivery
Innovating Drug Delivery for Enhanced Patient CareTherapeutic Delivery is a prestigious journal dedicated to advancing the field of Pharmaceutical Science, published by Newlands Press Ltd. Since its inception in 2010, this journal has become a vital resource for researchers and professionals alike, focusing on innovative drug delivery systems and therapeutic approaches that enhance patient care. With an impressive impact factor reflective of its credibility and scholarly influence, Therapeutic Delivery is currently ranked in the Q2 quartile and placed at Rank #64 out of 183 in the realm of Pharmacology, Toxicology, and Pharmaceutics, showcasing its prominence in the field. The journal operates with an Open Access format, ensuring that groundbreaking research is readily available to a global audience. Based in the United Kingdom, it publishes comprehensive articles that cover a wide spectrum of topics within pharmaceutical sciences, from molecular mechanisms to clinical applications, thus catering to both academic and professional readerships. Researchers, students, and industry professionals will find Therapeutic Delivery an invaluable platform for sharing insights and fostering advancements in therapeutic methodologies.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
Advancing the future of drug delivery.CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS is an esteemed academic journal published by BEGELL HOUSE INC, focusing on the innovative field of drug delivery systems and therapeutic carriers. With an ISSN of 0743-4863 and E-ISSN 2162-660X, this journal serves as a pivotal resource for researchers, professionals, and students engaged in pharmaceutical sciences and pharmacology. Spanning from 1984 to 2024, it has sustained its relevance in an evolving landscape, holding a commendable Q2 ranking in both Medicine (miscellaneous) and Pharmaceutical Science, as well as a Q3 ranking in Pharmacology for 2023. The journal is well-regarded for its critical and comprehensive reviews that enhance understanding and drive advancements in therapeutic applications. Access options are variable, providing insights into contemporary practices and innovations that shape drug delivery strategies. With a strong emphasis on interdisciplinary approaches, CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS not only fosters scholarly dialogue but also propels forward the critical field of therapeutic delivery, making it a valuable asset for anyone looking to deepen their knowledge and influence within this dynamic area of study.
International Journal of Pharmaceutics-X
Transforming discoveries into solutions for global health.International Journal of Pharmaceutics-X is a premier open access journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmaceutical sciences. Launched in 2019, this journal has quickly ascended to the Q1 category in the 2023 Category Quartiles, reflecting its high impact and the quality of research it promotes. With a current Scopus ranking of #49 out of 183 in the Pharmacology, Toxicology and Pharmaceutics category, this journal occupies the 73rd percentile, showcasing its significant influence within the scholarly community. Emphasizing innovative research and novel applications, the International Journal of Pharmaceutics-X offers a platform for researchers, professionals, and students to disseminate their findings, making crucial contributions to the global pharmaceutical landscape. The journal is based in the Netherlands, presenting a vibrant hub for scientific discourse and collaboration in a rapidly evolving field.
JOURNAL OF CONTROLLED RELEASE
Empowering breakthroughs in drug delivery and therapeutics.JOURNAL OF CONTROLLED RELEASE is a premier academic journal published by Elsevier that is dedicated to advancing the field of pharmaceutical science with a focus on drug delivery systems. Established in 1984, the journal has consistently served as a vital platform for disseminating high-quality research and innovative ideas in the area of controlled release technologies. With an impressive impact factor and ranking in the Q1 category of Pharmaceutical Science, it ranks #3 out of 183 in Scopus for its field, reflecting its influence and significance within the academic community, as noted by its percentile of 98th. The journal encompasses a wide range of topics, including polymer science, pharmacokinetics, and bioengineering, ensuring it remains at the forefront of pharmaceutical advancements. While currently not offering open access options, the journal serves a diverse audience of researchers, professionals, and students who are eager to push the boundaries of knowledge in drug delivery and therapeutics. For those looking to make impactful contributions in this dynamic field, JOURNAL OF CONTROLLED RELEASE is an essential resource for both foundational studies and cutting-edge research findings.
AAPS PHARMSCITECH
Bridging Science and Technology in Pharmaceutical ResearchAAPS PHARMSCITECH is a prestigious peer-reviewed journal published by Springer, focusing on the dynamic field of pharmaceutical sciences and technology. With an ISSN of 1530-9932, it provides a vital platform for disseminating cutting-edge research that spans key areas including drug discovery, pharmacology, toxicology, and ecological impacts of pharmaceuticals. The journal is recognized for its rigorous scientific contributions, currently holding a commendable Q2 quartile ranking across several relevant categories, including Agronomy and Crop Science, Aquatic Science, and Medicine in 2023. Notably, it ranks 43rd out of 183 in the Scopus Pharmacology, Toxicology, and Pharmaceutics category, placing it in the 76th percentile of its field. Aiming to foster innovation and collaboration among researchers, professionals, and students, AAPS PHARMSCITECH is committed to advancing scientific knowledge and addressing contemporary challenges in pharmaceutical sciences. The journal offers various access options to ensure wide dissemination of research findings, making it an essential resource for those dedicated to enhancing public health through pharmaceutical advancements.
CURRENT PHARMACEUTICAL DESIGN
Transforming Research into Revolutionary Drug SolutionsCURRENT PHARMACEUTICAL DESIGN is a leading journal in the fields of Drug Discovery and Pharmacology, published by Bentham Science Publishers Ltd in the dynamic United Arab Emirates. With an impressive historical span from 1995 to 2024, this journal serves as a vital platform for disseminating innovative research findings, breakthrough methodologies, and critical reviews that shape the future of pharmaceutical sciences. Ranked Q2 in both Drug Discovery and Pharmacology categories according to the 2023 metrics, it places itself within the top-tier percentile, catering to a diverse audience of researchers, industry professionals, and students. The journal’s commitment to high-quality research exploration is evidenced by its Scopus ranking, where it is positioned favorably within its category ranks. Although currently not Open Access, CURRENT PHARMACEUTICAL DESIGN remains an essential resource for those looking to stay at the forefront of pharmacological advancements and drug development strategies.
Pharmaceuticals
Pioneering Research in Pharmaceuticals and TherapeuticsPh pharmaceuticals is a leading peer-reviewed journal published by MDPI, focused on the dynamic fields of pharmaceutical science, drug discovery, and molecular medicine. Since its inception, the journal has established itself as a vital resource for researchers and practitioners, boasting an impressive impact factor reflected in its Q1 and Q2 quartile rankings across multiple categories, including Pharmaceutical Science and Drug Discovery. As an open access journal since 2009, Pharmaceuticals promotes the dissemination of cutting-edge research and innovative findings globally, facilitating collaboration and knowledge sharing among scientists. With a robust ranking in Scopus, specifically at Rank #56 in Pharmaceutical Science and Rank #65 in Drug Discovery, the journal serves as a critical platform for advancing the field and supporting future developments in therapeutics and pharmaceuticals. Based in Switzerland, Pharmaceuticals continues to inspire a diverse readership of scholars and healthcare professionals who are dedicated to improving health outcomes through innovative research.